International Customer Service Representative (Evening Shift)
Natera- Full Time
- Junior (1 to 2 years)
Candidates must possess at least 3 years of experience in safety information case processing, including receipt, triage, numbering, content verification, database input, and QC. They should also have a business-level understanding of Japanese, a higher education degree (such as associate's or bachelor's), and the ability to build positive relationships with other departments and team members.
The Pharmacovigilance Specialist will be responsible for receiving and triaging safety information, assigning numbering, performing content verification, inputting data into databases, conducting initial assessments for PMDA reports, and performing QC. They will also create and QC explanation texts (in both Japanese and English), prepare and QC reports for submission to the PMDA, conduct investigations (queries) to obtain additional information, detect and evaluate signals from domestic and international literature and overseas measures, input data into databases and QC, and create reports for submission to PMDA. Additionally, the role involves preparing draft safety reports, infection reports, and annual reports, as well as creating line lists for clinical trial sites, and collaborating with various stakeholders including customers and clinical trial facilities.
Advanced analytics and clinical research services
IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their services utilize extensive data resources and technology to create connections within healthcare, allowing clients to gain insights that help speed up the development and marketing of new medical treatments. This process is facilitated by their IQVIA Connected Intelligence™ system, which offers quick and flexible insights. IQVIA stands out from competitors by focusing on patient privacy, employing various technologies to protect individual data. The company's goal is to enhance healthcare outcomes by supporting biotech, pharmaceutical, and medical device companies, as well as researchers and government agencies, in understanding diseases and advancing medical science.